Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.150
+0.080 (7.48%)
At close: Mar 4, 2026, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Mar 4, 2026, 7:52 PM EST
Humacyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 1.57 | - | - | 1.57 | 1.26 | 1.49 | |
| Revenue Growth (YoY) | - | - | - | 23.91% | -15.29% | -75.90% | |
| Cost of Revenue | 75.37 | 88.6 | 76.55 | 63.26 | 61.34 | 54.08 | |
| Gross Profit | -73.8 | -88.6 | -76.55 | -61.7 | -60.08 | -52.59 | |
| Selling, General & Admin | 30.89 | 25.8 | 20.39 | 22.88 | 21.13 | 12.01 | |
| Operating Expenses | 30.89 | 25.8 | 20.39 | 22.88 | 21.13 | 12.01 | |
| Operating Income | -104.69 | -114.4 | -96.94 | -84.58 | -81.21 | -64.6 | |
| Interest Expense | -10.67 | -9.28 | -6.6 | -6.2 | -4.35 | -2.2 | |
| Interest & Investment Income | 2.94 | 4.1 | 5.47 | 2.63 | 0.02 | 0.28 | |
| Other Non Operating Income (Expenses) | 21.39 | 3.92 | -0.26 | 0.42 | 0.06 | - | |
| EBT Excluding Unusual Items | -91.03 | -115.66 | -98.33 | -87.73 | -85.48 | -66.52 | |
| Merger & Restructuring Charges | -0.7 | - | - | - | -0.05 | - | |
| Other Unusual Items | 54.76 | -33.05 | -12.44 | 75.77 | 59.06 | - | |
| Pretax Income | -36.97 | -148.7 | -110.78 | -11.97 | -26.48 | -66.52 | |
| Net Income | -36.97 | -148.7 | -110.78 | -11.97 | -26.48 | -66.52 | |
| Net Income to Common | -36.97 | -148.7 | -110.78 | -11.97 | -26.48 | -66.52 | |
| Shares Outstanding (Basic) | 143 | 118 | 103 | 103 | 40 | 6 | |
| Shares Outstanding (Diluted) | 143 | 118 | 103 | 103 | 40 | 6 | |
| Shares Change (YoY) | 27.11% | 14.56% | 0.36% | 157.82% | 593.25% | -71.34% | |
| EPS (Basic) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -11.54 | |
| EPS (Diluted) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -11.54 | |
| Free Cash Flow | -106.4 | -99.69 | -75.59 | -72.18 | -81.41 | -55.89 | |
| Free Cash Flow Per Share | -0.74 | -0.84 | -0.73 | -0.70 | -2.04 | -9.69 | |
| Operating Margin | -6663.85% | - | - | -5404.35% | -6429.77% | -4332.66% | |
| Profit Margin | -2353.22% | - | - | -764.54% | -2096.36% | -4461.70% | |
| Free Cash Flow Margin | -6772.95% | - | - | -4611.95% | -6445.76% | -3748.22% | |
| EBITDA | -97.32 | -107.21 | -89.22 | -76.37 | -72.97 | -56.25 | |
| D&A For EBITDA | 7.37 | 7.19 | 7.72 | 8.21 | 8.24 | 8.35 | |
| EBIT | -104.69 | -114.4 | -96.94 | -84.58 | -81.21 | -64.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.